<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02608008</url>
  </required_header>
  <id_info>
    <org_study_id>EchoNav</org_study_id>
    <nct_id>NCT02608008</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of EchoNavigator System Release II During Structural Heart Interventions</brief_title>
  <acronym>EchoNav</acronym>
  <official_title>Safety and Efficacy of EchoNavigator System Release II (Philips, Andover, MA) During Structural Heart Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect data regarding the safety and efficacy of
      EchoNavigator System Release II during structural heart interventions in the clinical
      practice. Data of procedures with and without the use of EchoNavigator System Release II will
      be collected, analysed and evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EchoNavigator System Release II is a CE certified innovative periinterventional imaging
      modality used in our clinic of cardiology, pulmonology and angiology during structural heart
      interventions like transfemoral aortic valve Implantation (TAVI), MitraClip implantation,
      patent foramen ovale (PFO), atrial septal defect (ASD) and left atrial appendage (LAA).
      During this interventions EchoNavigator is able to combine live X-ray Images and 3D Echo
      guidance to enhance the efficiency of the procedure.

      Specific periprocedural data parameter, e.g. procedure duration, radiation time, radiation
      dose, transseptal punction time (e.g.LAA) and contrast agent amount will be collected and
      analysed. The same data characteristics from the same procedures but without the
      periinterventional use of the EchoNavigator System Release II will be collected, analysed and
      compared with the data described above. A retrospective data collection between 2013 - 2017
      of n=500 patients will be conducted.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of procedure time</measure>
    <time_frame>baseline</time_frame>
    <description>During interventions with and without the use of EchoNavigator System Release II</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of area dose product</measure>
    <time_frame>baseline</time_frame>
    <description>During procedures with and without the use of EchoNavigator System Release II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of contrast agent amount</measure>
    <time_frame>baseline</time_frame>
    <description>During procedures with and without the use of EchoNavigator System Release II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of data measurements of fluoroscopy time</measure>
    <time_frame>baseline</time_frame>
    <description>During procedures with and without the use of EchoNavigator System Release II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of duration of the transeptal punction</measure>
    <time_frame>baseline</time_frame>
    <description>During mitraClip implantations, ASD/PFO with and without the use of EchoNavigator System Release II.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Cardiac Imaging Techniques</condition>
  <arm_group>
    <arm_group_label>Data analysis transfemoral aortic valve implantation</arm_group_label>
    <description>Periinterventional data analysis during structural heart procedures like transfemoral aortic valve implantation with and without the use of EchoNavigator System Release II.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Data analysis MitraClip</arm_group_label>
    <description>Periinterventional data analysis during structural heart procedures like MitraClip Implantations with and without the use of EchoNavigator System Release II.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Data analysis PFO</arm_group_label>
    <description>Periinterventional data analysis during structural heart procedures like PFO implantations with and without the use of EchoNavigator System Release II.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Data analysis ASD</arm_group_label>
    <description>Periinterventional data analysis during structural heart procedures like ASD implantations with and without the use of EchoNavigator System Release II.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Data analysis</intervention_name>
    <description>data parameters Analysis</description>
    <arm_group_label>Data analysis ASD</arm_group_label>
    <arm_group_label>Data analysis MitraClip</arm_group_label>
    <arm_group_label>Data analysis PFO</arm_group_label>
    <arm_group_label>Data analysis transfemoral aortic valve implantation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult male or female patients undergoing structural heart interventions like transfemoral
        aortic valve Implantation (TAVI), MitraClip implantation, patent foramen ovale (PFO),
        atrial septal defect (ASD) and left atrial appendage (LAA) with or without the
        periintervention use of the EchoNavigator System Release II.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male or female patients of any ethnic origin aged &gt; 18 years

          -  Signed and dated informed consent for the prospective study part

        Exclusion Criteria:

          -  &lt; 18 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malte Kelm, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Cardiology, Pulmonary Disease and Vascular Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonary Disease and Vascular Medicine</name>
      <address>
        <city>Dusseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>November 16, 2015</study_first_submitted>
  <study_first_submitted_qc>November 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>July 8, 2019</last_update_submitted>
  <last_update_submitted_qc>July 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik f√ºr Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>PD Dr. med. Tobias Zeus</investigator_title>
  </responsible_party>
  <keyword>3D-Ultrasound</keyword>
  <keyword>Live X-rays</keyword>
  <keyword>EchoNavigator System</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

